Literature DB >> 32472645

Clinical and genetic characteristics of type I sialidosis patients in mainland China.

Rui-Juan Lv1, Tao-Ran Li1,2, Yu-Di Zhang1,3, Xiao-Qiu Shao1, Qun Wang1, Li-Ri Jin4.   

Abstract

OBJECTIVE: Type I sialidosis (ST-1) is a rare autosomal recessive inherited disorder. To date, there has been no study on ST-1 patients in mainland China.
METHODS: We reported in detail the cases of five Chinese ST-1 patients from two centers, and summarized all worldwide cases. Then, we compared the differences between Chinese and foreign patients.
RESULTS: A total of 77 genetically confirmed ST-1 patients were identified: 12 from mainland China, 23 from Taiwan, 10 from other Asian regions, and 32 from European and American regions. The mean age of onset was 16.0 ± 6.7 years; the most common symptoms were myoclonus seizures (96.0%), followed by ataxia (94.3%), and blurred vision (67.2%). Compared to other groups, the onset age of patients from mainland China was much younger (10.8 ± 2.7 years). The incidence of visual impairment was lower in patients from other Asian regions than in patients from mainland China and Taiwan (28.6% vs. 81.8%-100%). Cherry-red spots were less frequent in the Taiwanese patients than in patients from other regions (27.3% vs. 55.2%-90.0%). Furthermore, 48 different mutation types were identified. Chinese mainland and Taiwanese patients were more likely to carry the c.544A > G mutation (75% and 100%, respectively) than the patients from other regions (only 0%-10.0%). Approximately 50% of Chinese mainland patients carried the c.239C > T mutation, a much higher proportion than that found in the other populations. In addition, although the brain MRI of most patients was normal, 18 F-FDG-PET analysis could reveal cerebellar and occipital lobe hypometabolism.
INTERPRETATION: ST-1 patients in different regions are likely to have different mutation types; environmental factors may influence clinical manifestations. Larger studies enrolling more patients are required.
© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Entities:  

Mesh:

Year:  2020        PMID: 32472645      PMCID: PMC7318099          DOI: 10.1002/acn3.51058

Source DB:  PubMed          Journal:  Ann Clin Transl Neurol        ISSN: 2328-9503            Impact factor:   4.511


  42 in total

1.  Pitfalls in Diagnosing Neuraminidase Deficiency: Psychosomatics and Normal Sialic Acid Excretion.

Authors:  Imre F Schene; Viera Kalinina Ayuso; Monique de Sain-van der Velden; Koen L I van Gassen; Inge Cuppen; Peter M van Hasselt; Gepke Visser
Journal:  JIMD Rep       Date:  2015-07-05

2.  Multimodality evoked potentials and EEG in a case of cherry red spot-myoclonus syndrome and alpha-neuraminidase deficiency (sialidosis type 1)

Authors:  J P Louboutin; B Nogues; C Caillaud; B Elie
Journal:  Eur Neurol       Date:  1995       Impact factor: 1.710

3.  Lysosomal multienzymatic complex-related diseases: a genetic study among Portuguese patients.

Authors:  M F Coutinho; L Lacerda; S Macedo-Ribeiro; E Baptista; H Ribeiro; M J Prata; S Alves
Journal:  Clin Genet       Date:  2011-03-01       Impact factor: 4.438

4.  Biochemical study of sialidosis type I in a Russian family.

Authors:  I V Tsvetkova; N A Petushkova; T V Zolotuchina; V I Kucharenko; E L Rosenfeld
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

5.  A longitudinal study of Taiwanese sialidosis type 1: an insight into the concept of cherry-red spot myoclonus syndrome.

Authors:  S-C Lai; R-S Chen; Y-H Wu Chou; H-C Chang; L-Y Kao; Y-Z Huang; Y-H Weng; J-K Chen; W-L Hwu; C-S Lu
Journal:  Eur J Neurol       Date:  2009-04-14       Impact factor: 6.089

6.  Mucolipidosis I--a sialidosis.

Authors:  J Sphranger; J Gehler; M Cantz
Journal:  Am J Med Genet       Date:  1977

7.  Sialidosis type I carrying V217M/G243R mutations in lysosomal sialidase: an autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia.

Authors:  Toshiki Uchihara; Ken-ichi Ohashi; Masanobu Kitagawa; Morito Kurata; Ayako Nakamura; Katsuiku Hirokawa; Tsutomu Kasuga; Takayoshi Kobayashi
Journal:  Acta Neuropathol       Date:  2009-05-05       Impact factor: 17.088

8.  Spectral optical coherence tomography in a patient with type I sialidosis.

Authors:  Zofia Michalewska; Agata Gajos; Janusz Michalewski; Jerzy Nawrocki; Alexey V Pshezhetsky; Andrzej Bogucki
Journal:  Med Sci Monit       Date:  2011-10

9.  Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis.

Authors:  Wenjun Zou; Xin Wang; Guohong Tian
Journal:  BMC Ophthalmol       Date:  2016-03-22       Impact factor: 2.209

Review 10.  Sialidosis: A Review of Morphology and Molecular Biology of a Rare Pediatric Disorder.

Authors:  Aiza Khan; Consolato Sergi
Journal:  Diagnostics (Basel)       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.